logo-loader
RNS
Animalcare Group

Animalcare Group PLC - Director/PDMR Shareholding

RNS Number : 7161B
Animalcare Group PLC
10 June 2019
 

 10 June 2019

 

ANIMALCARE GROUP PLC

 (the "Company")

Grant of options to Persons Discharging Managerial Responsibility ("PDMRs")

 

Animalcare Group plc (AIM: ANCR), the pan-European Animal Health business, announces that, on 6 June 2019, nil-cost options over a total of 425,279 ordinary shares with a nominal value of 20p per share ("the Options") were awarded to certain Executive Directors and PDMRs of the Company and to members of the Leadership Team pursuant to the Company's Long Term Incentive Plan.

 

The awards will normally vest three years after the date of grant subject to the following performance criteria being met over the three year financial period ending 31 December 2021.  The Options will vest to the extent the following performance conditions based on EPS and TSR are met:

 

Earnings Per Share growth

Extent to which EPS tranche will vest

Less than 3%

0%

3%

25%

8%

100%

Between 3% and 8%

Between 25% and 100% on a straight line basis

 

Rank of the Company's TSR compared to the Comparator Group

Extent to which the TSR tranche will vest

Upper quartile or above

100%

Between median and upper quartile

Pro rata between 25% and 100% on a ranking basis

Median

25%

Below median

0%

 

50% of the option award will be subject to the EPS performance condition and the remaining 50% will be subject to the TSR performance condition. Accordingly, if one of the performance conditions is met but the other is not, the Option award will vest in part. 

 

After the grant of the Options, the PDMRs set out below hold the following Options and ordinary shares:

 

PDMR

Options Awarded

Total Options

Ordinary Shares

Jennifer Winter

177,570

 

177,570

 

0

Chris Brewster

  76,636

 

  76,636

280,513

 

Options over a further 171,073 ordinary shares were granted to members of the Leadership Team.

 

The notification in respect of the Option Awards set out in the Annex below was made subject to the requirements of Article 19 of the Market Abuse Regulation:

 

ANNEX

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Name

Jennifer Winter, Chief Executive Officer

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above - Ms Winter is classified as a PDMR of the Company

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Animalcare Group plc

b)

LEI

 

 213800A7XPQ528RMCC72

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each

b)

Identification code 

 

 GB0032350695

c)

 

Nature of the transaction(s)

 

Issue of options

d)

 

Price(s) and volume(s)

Volume(s):

Nil cost options over 177,570 shares

Price:

£Nil

e)

 

Aggregated information 

- Aggregated volume

- Price

 N/A

 

f)

 

Date of the transaction

6 June 2019

g)

 

Place of the transaction

Outside a trading venue

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Name

Chris Brewster, Chief Financial Officer

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above - Mr Brewster is classified as a PDMR of the Company

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Animalcare Group plc

b)

LEI

 

 213800A7XPQ528RMCC72

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each

b)

Identification code 

 

 GB0032350695

c)

 

Nature of the transaction(s)

 

Issue of options

d)

 

Price(s) and volume(s)

Volume(s):

Nil cost options over 76,636 shares

Price:

£Nil

e)

 

Aggregated information 

- Aggregated volume

- Price

 N/A

 

f)

 

Date of the transaction

6 June 2019

g)

 

Place of the transaction

Outside a trading venue

 

Animalcare Group plc

Tel: 01904 487 687

Chris Brewster, Chief Financial Officer

and Company Secretary

 

 

Panmure Gordon - Nominated Adviser and Broker

Tel: 020 7886 2500

Corporate Finance

 

Freddy Crossley / Emma Earl

 

Corporate Broking

 

 

Consilium Strategic Communications

Tel: 020 3709 5709

Amber Fennell/Angela Gray/Olivia Manser

Animalcare@consilium-comms.com

 

 

About Animalcare www.animalcaregroup.co.uk

Animalcare Group plc is a UK AIM listed veterinary sales and marketing organisation resulting from the merger of Animalcare and Ecuphar NV in July 2017.  Animalcare operates in 32 countries in Europe and a further 16 worldwide.  The company is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBXGDLDUBBGCG
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read